Medications for Deep Venous Thrombosis

kg). It has the advantage of fixed dosing and is less likely to cause thrombocytopenia. Direct thrombin inhibitors Dabigatran 150 mg orally twice a day is given only after an initial 5 days of treatment with LMWH. It is typically started within 6 to 12 hours after the last dose of a twice-daily LMWH regimen and within 12 to 24 hours after a once-daily regimen. Parenteral direct thrombin inhibitors (argatroban, bivalirudin, desirudin) are available but do not have a role in treatment or prevention of DVT or PE. Argatroban may be useful to treat DVT in patients with heparin-induced thrombocytopenia. Vitamin K antagonists (warfarin) Warfarin is a treatment option for patients with DVT who are not pregnant. It is also an option for patients with severe renal dysfunction. Warfarin is also a second-line option for patients with cancer- associated VTE. Warfarin 5 to 10 mg can be started immediately along with heparin because it takes about 5 days to achieve desired therapeutic effect. Older patients and patients with a liver disorder typically require lower warfarin doses. Therapeutic goal is an international normalized ratio (INR) of 2.0 to 3.0. INR is monitored weekly for the first 1 to 2 months of
